See more : Valeura Energy Inc. (PNWRF) Income Statement Analysis – Financial Results
Complete financial analysis of Intuitive Surgical, Inc. (ISRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intuitive Surgical, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- WELLYSUN INC (6988.TW) Income Statement Analysis – Financial Results
- Happy Belly Food Group Inc. (VGANF) Income Statement Analysis – Financial Results
- Silver Egg Technology Co., Ltd. (3961.T) Income Statement Analysis – Financial Results
- Future Farm Technologies Inc. (FFRMF) Income Statement Analysis – Financial Results
- Birmingham Sports Holdings Limited (2309.HK) Income Statement Analysis – Financial Results
Intuitive Surgical, Inc. (ISRG)
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B | 2.38B | 2.13B | 2.27B | 2.18B | 1.76B | 1.41B | 1.05B | 874.92M | 600.83M | 372.68M | 227.34M | 138.80M | 91.68M | 72.02M | 51.67M | 26.62M | 10.19M | 0.00 |
| Cost of Revenue | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.80M | 814.30M | 806.50M | 717.90M | 670.90M | 608.50M | 483.50M | 383.00M | 301.12M | 254.14M | 186.54M | 124.85M | 73.77M | 50.81M | 47.65M | 34.58M | 28.22M | 13.28M | 7.03M | 0.00 |
| Gross Profit | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.19B | 1.89B | 1.58B | 1.41B | 1.59B | 1.57B | 1.27B | 1.03B | 751.05M | 620.78M | 414.29M | 247.84M | 153.57M | 87.99M | 44.03M | 37.44M | 23.46M | 13.35M | 3.16M | 0.00 |
| Gross Profit Ratio | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | 69.92% | 70.12% | 69.89% | 66.18% | 66.32% | 70.38% | 72.07% | 72.49% | 72.89% | 71.38% | 70.95% | 68.95% | 66.50% | 67.55% | 63.39% | 48.03% | 51.98% | 45.39% | 50.12% | 31.02% | 0.00% |
| Research & Development | 998.80M | 879.00M | 671.00M | 595.10M | 557.30M | 418.10M | 328.60M | 239.60M | 197.40M | 178.00M | 167.70M | 170.00M | 140.20M | 116.00M | 95.10M | 79.37M | 48.86M | 29.78M | 17.35M | 17.81M | 16.19M | 16.79M | 13.85M | 11.73M | 11.13M | 23.21M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 9.34M | 7.57M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.75M | 11.58M | 7.57M |
| Operating Expenses | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 944.90M | 837.90M | 869.00M | 741.70M | 692.20M | 579.00M | 474.80M | 373.61M | 309.94M | 207.54M | 140.48M | 84.80M | 66.81M | 55.91M | 57.66M | 43.84M | 35.62M | 22.71M | 30.77M |
| Cost & Expenses | 5.36B | 4.65B | 3.89B | 3.31B | 3.10B | 2.52B | 2.07B | 1.76B | 1.64B | 1.59B | 741.70M | 1.30B | 1.06B | 857.80M | 674.73M | 564.08M | 394.09M | 265.33M | 158.57M | 117.62M | 103.56M | 92.24M | 72.06M | 48.90M | 29.74M | 30.77M |
| Interest Income | 192.10M | 29.70M | 69.30M | 157.20M | 116.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 29.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 421.80M | 380.40M | 317.00M | 282.50M | 199.70M | 120.10M | 95.00M | 88.90M | 89.50M | 74.40M | 67.30M | 57.80M | 46.50M | 40.40M | 34.58M | 25.08M | 13.03M | 35.27M | 6.73M | 7.11M | 10.63M | 4.55M | 4.71M | 4.75M | 2.24M | 0.00 |
| EBITDA | 2.17B | 1.58B | 1.82B | 1.05B | 1.37B | 1.32B | 1.16B | 1.05B | 740.00M | 619.20M | 919.80M | 935.90M | 741.30M | 595.60M | 377.44M | 335.92M | 219.77M | 107.36M | 75.50M | 21.18M | -1.25M | -15.67M | -15.67M | -17.53M | -17.31M | -30.77M |
| EBITDA Ratio | 30.45% | 25.35% | 31.89% | 24.09% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 38.39% | 36.58% | 38.27% | 33.44% | 20.21% | -1.79% | -21.70% | -30.41% | -65.42% | -169.80% | 0.00% |
| Operating Income | 1.77B | 1.21B | 1.82B | 773.60M | 1.37B | 1.20B | 1.05B | 945.20M | 740.00M | 544.80M | 852.50M | 878.10M | 694.80M | 555.20M | 377.44M | 310.84M | 206.74M | 107.36M | 68.77M | 21.18M | -11.88M | -20.22M | -20.38M | -22.28M | -19.55M | -30.77M |
| Operating Income Ratio | 24.80% | 19.47% | 31.89% | 17.75% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 35.53% | 34.41% | 28.81% | 30.25% | 15.26% | -12.96% | -28.07% | -39.45% | -83.67% | -191.81% | 0.00% |
| Total Other Income/Expenses | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M | 18.50M | 4.20M | 18.40M | 15.80M | 14.90M | 17.10M | 18.67M | 24.37M | 30.49M | 12.78M | 5.04M | 3.02M | 2.26M | 1.80M | 42.00K | -108.00K | 0.00 | 0.00 |
| Income Before Tax | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 980.80M | 758.50M | 549.00M | 870.90M | 893.90M | 709.70M | 572.30M | 396.11M | 335.20M | 237.23M | 120.14M | 73.81M | 24.20M | -9.62M | -18.42M | -20.34M | -22.39M | 0.00 | 0.00 |
| Income Before Tax Ratio | 27.50% | 25.82% | 33.10% | 27.69% | 33.54% | 34.36% | 35.04% | 36.27% | 31.81% | 25.75% | 38.45% | 41.03% | 40.39% | 40.50% | 37.65% | 38.31% | 39.48% | 32.24% | 32.47% | 17.44% | -10.50% | -25.58% | -39.36% | -84.08% | 0.00% | 0.00% |
| Income Tax Expense | 141.60M | 262.40M | 162.20M | 140.20M | 120.40M | 154.50M | 436.50M | 244.90M | 169.70M | 130.20M | 199.90M | 237.30M | 214.60M | 190.50M | 163.51M | 130.89M | 92.70M | 48.09M | -20.33M | 726.00K | -2.26M | -1.80M | -3.68M | -3.75M | -1.13M | 29.44M |
| Net Income | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 660.00M | 735.90M | 588.80M | 418.80M | 671.00M | 656.60M | 495.10M | 381.80M | 232.61M | 204.32M | 144.54M | 72.04M | 94.13M | 23.48M | -9.62M | -18.42M | -16.70M | -18.52M | -18.42M | -29.44M |
| Net Income Ratio | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | 30.29% | 21.09% | 27.21% | 24.69% | 19.65% | 29.62% | 30.14% | 28.17% | 27.02% | 22.11% | 23.35% | 24.06% | 19.33% | 41.41% | 16.91% | -10.50% | -25.58% | -32.32% | -69.57% | -180.68% | 0.00% |
| EPS | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 | 1.76 | 1.26 | 1.86 | 1.83 | 1.40 | 1.08 | 0.67 | 0.58 | 0.42 | 0.22 | 0.30 | 0.08 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| EPS Diluted | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 | 2.08 | 1.73 | 1.23 | 1.86 | 1.78 | 1.37 | 1.05 | 0.66 | 0.57 | 0.41 | 0.21 | 0.28 | 0.07 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| Weighted Avg Shares Out | 351.20M | 355.70M | 356.10M | 351.00M | 346.20M | 341.10M | 335.10M | 344.70M | 333.90M | 332.10M | 360.97M | 358.20M | 352.80M | 352.80M | 344.68M | 349.89M | 340.48M | 330.63M | 315.63M | 303.24M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
| Weighted Avg Shares Out (Dil) | 357.40M | 362.00M | 365.80M | 360.90M | 358.50M | 356.40M | 348.90M | 353.70M | 341.10M | 339.30M | 360.97M | 369.90M | 361.80M | 362.70M | 352.85M | 359.49M | 351.19M | 342.84M | 337.39M | 314.78M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
Only Have $1,000 to Invest? Buy These 3 Stocks Right Now
“It takes money to make money.” While that used to be true on Wall Street, it is no longer the case.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
3 Best Growth Stocks to Own for the Next 10 Years
During times of market volatility, it's always good for long-term investors to take a breath and zoom out. That doesn't mean getting out of the markets as fast as possible.
Intuitive Surgical: Detached From Fundamentals
Against expectations of a growth slowdown, Intuitive Surgical's results have been strong in 2024, supported by robust procedure volumes and a solid da Vinci 5 launch. Intuitive Surgical's margins picked up in Q2, despite the scaling of da Vinci 5...
2 Top Growth Stocks You Can Still Buy in August
Different companies have responded to the bull market in a variety of ways. Intuitive Surgical has seen shares soar as procedure volume and revenue increase steadily.
Intuitive Surgical, Inc. (ISRG) Stock Drops Despite Market Gains: Important Facts to Note
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $486.55, signifying a -0.79% move from its prior day's close.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Forget Nvidia: Billionaires Are (Still) Selling It and Buying Shares of These 2 Hypergrowth Stocks Hand Over Fist Instead
Form 13Fs allow investors to see which stocks Wall Street's prominent money managers have been buying and selling. More than a half-dozen billionaires dumped shares of artificial intelligence (AI) leader Nvidia for a third consecutive quarter.
Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now
Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Source: https://incomestatements.info
Category: Stock Reports